JBIO
Jade BiosciencesANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
JBIO vs peer average
83/100
JBIO vs. peer average (A vs. C)
Grade spread
A 1 · B 4 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
PRME is the first available peer comparator.
Prime Medicine is mainly a development-stage valuation and funding comp rather than an indication match, which makes it helpful for benchmarking market tolerance for pre-proof-of-concept platforms.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JBIO
Jade Biosciences
PRME
Prime Medicine
Grade
A
F
Momentum
82
11
Value
41
41
Sentiment
68
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs PRME
JBIO / PRME
Grade Position
Above peers
JBIO vs. peer average (A vs. C)
83/100
Momentum
82
JBIOValue
41
JBIOSentiment
68
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JBIO
PRME is the first peer returned for this comparison set.